FDA signs off on Adaptimmune's Tecelra as the first engineered cell therapy for a solid tumor

cafead

Administrator
Staff member
  • cafead   Aug 02, 2024 at 11:42: AM
via Adaptimmune has won accelerated FDA approval for Tecelra (afami-cel), a treatment for metastatic or unresectable synovial sarcoma.

article source